
Healthcare / Medical Devices · NSE / BSE
Founded in 1982, Sanstar Limited is a leading Indian manufacturer of specialty plant-based products and ingredient solutions for food, pet food, and industrial applications. Its extensive product portfolio includes liquid glucose, dried glucose solids, maltodextrin powder, dextrose monohydrate, native and modified maize starches, and by-products such as germ, gluten, fiber, and fortified proteins, serving as thickeners, stabilizers, sweeteners, emulsifiers, and functional additives. The company operates two manufacturing facilities in Dhule, Maharashtra, and Kutch, Gujarat, covering 10.68 million sq. ft. with an installed capacity of 363,000 tons per annum, making it India’s fifth-largest corn-based specialty ingredients producer. Sanstar exports to 49 countries across Asia, Africa, the Middle East, America, Europe, and Oceania, with a pan-India presence in 22 states, and as of March 31, 2024, employs 271 people, including 60 permanent staff.
Price Band
₹90 – ₹95
Issue Size
₹510 Cr
Lot Size
150 shares
GMP
+26.3%
Est. Listing
₹120
at current GMP
Subscribed
82.98x
overall
Open
19 Jul 2024
Close
23 Jul 2024
Allotment
24 Jul 2024
Refund
25 Jul 2024
Demat Credit
26 Jul 2024
Listing
26 Jul 2024
Last updated: 19 Oct 2026
Current Premium
Issue Price (Upper)
₹95
Band: ₹90 – ₹95
Estimated Listing Price
₹120
Upper price + GMP
Lot Size
150 shares
Min investment ₹14,250
Estimated Profit / Lot
₹3,750
150 × ₹25
Grey Market Premium trend
+₹25
▲ 0 today
Updated less than a minute ago
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 31 Oct 2026 | +₹25 | 26.3% | ₹120 |
| 30 Oct 2026 | +₹25 | 26.3% | ₹120 |
| 29 Oct 2026 | +₹23 | 23.7% | ₹118 |
GMP is unofficial market data. Not a guarantee of listing performance.
Sanstar Limited is bringing an initial public offering (IPO) in the Healthcare / Medical Devices sector with an aggregate issue size of ₹510.15 Crores. The shares are offered at a price band of ₹90 to ₹95 per equity share on NSE and BSE. Currently, market analysts recommend evaluating the company's financial valuation, price-to-earnings (P/E) multiple, and peer comparison prior to submitting bids.
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Following the close of bidding on 2024-07-23, the basis of allotment is scheduled to be finalized on 2024-07-24. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Link Intime India Private Limited) or the BSE allotment checking window.
The latest grey market premium for Sanstar Limited IPO is ₹25, which indicates an expected listing price of ₹120.
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.